Contact Us
Blog
Subscribe to this list via RSS Blog posts tagged in blood clots

Xarelto lawsuit, Chicago personal injury lawyersWith nearly two billion dollars in sales in the United States last year, Xarelto is now considered a best seller among the category of drugs meant to replace the age-old anticoagulant, warfarin. And why not? After all, Xarelto users are not forced to follow the same diet restrictions and monitoring needed as their warfarin counterparts. Plus, patients only have to take Xarelto once daily. But, then again (as is often the case) not everything is quite as it seems.

Bayer and Johnson & Johnson, the manufacturers of Xarelto, are currently facing more than 5,000 lawsuits from patients and their families; 500 of those involve Xarelto patient deaths. Their attorneys say that the company knew their drug was dangerous, and that the company intentionally deceived doctors, patients, and even medical journals. Of course, the manufacturers continue to defend their drug, saying it is safer than its competitor, but recent documents suggest that the claims against them may actually hold some truth.

Clinical Trials Under Fire

...

Bayer Yaz settlement, Chicago defective drugs lawyerAccording to plaintiffs in the case against Bayer, the makers of the drospierenone-containing Yaz and Yasmin, and Barr Laboratories makers of the generic form, Ocella, the drugs have caused arterial clots that resulted in life-threatening complications, including stroke and heart attack.

Recently, Bayer agreed to pay $56.9 million to establish a settlement program for those claims, but if fewer than 97.5 percent of the eligible plaintiffs fail to participate, they will be able to withdraw. It is not clear at this time if the manufacturers of Ocella will contribute to the settlement, or, if so, how much.

Court documents originally contained 12,000 files, all with multiple plaintiffs, making it the largest multidistrict litigation in the nation at its height. But the defendants reportedly argued that some of the plaintiffs had duplicate claims, and that others had never taken drospierenone-containing birth control. By February, they had boiled it down to just 3,400 claims. Some of the cases dismissed were remanded to their home district to be dismissed, settled, or tried. The first is set to begin trial in late July.

...
To Top